ADCYAP1 and Alzheimer disease: In the context of cognition, PACAP beneficial effects have been related to an increase of BDNF expression in AD and HD murine models (Rat et al., 2011; Cabezas-Llobet et al., 2018; Solés-Tarrés et al., 2020).